(Q43569889)

24 November 2017

title

Development and characterization of a novel peroral peptide drug delivery system (English)

1 reference

24 November 2017

1 reference

Dorkoosh FA

1

1 reference

24 November 2017

Verhoef JC

2

1 reference

24 November 2017

Borchard G

3

1 reference

24 November 2017

Rafiee-Tehrani M

4

1 reference

24 November 2017

Junginger HE

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Journal of Controlled Release

24 November 2017

published in

1 reference

24 November 2017

volume

71

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

307-318

1 reference

Oral controlled release technology for peptides: status and future prospects

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Targeting of peptide and protein drugs to specific sites in the oral route

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Strategies for delivery of peptides utilizing absorption-enhancing agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Distribution of brush-border membrane peptidases along the rabbit intestine: implication for oral delivery of peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Regulation of the intestinal epithelial paracellular barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Intestinal Mucins in Health and Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Synthesis and characterization of superporous hydrogel composites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Synthesis of superporous hydrogels: hydrogels with fast swelling and superabsorbent properties

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

In vivo drug release behavior in dogs from a new colon-targeted delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Polymer-coated gelatin capsules as oral delivery devices and their gastrointestinal tract behaviour in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900232-2

7 January 2021

10.1016/S0168-3659(01)00232-2

Identifiers

DOI

1 reference

24 November 2017

1 reference